Patent · US Expired

C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

US6657086B2 · kind B2 · utility

0Cited by

7References

6Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Gerhard Jaehne · Frankfurt, DE
Volker Krone · Flörsheim, DE
Martin Bickel · Frankfurt am Main, DE
Matthias Gossel · Frankfurt am Main, DE

Key dates

Filing date	Aug 30, 2002
Grant date	Dec 2, 2003
Priority date	—
Expiry date	Aug 30, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Embodiments of the invention relate to C2-substituted indan-1-ols and to their physiologically acceptable salts and physiologically functional derivatives. Compounds of embodiments of the invention may include compounds of formula I in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for use as anorectics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.